PwC reviews 5CPA progs
March 20, 2014
Commissioned by the Federal
Department of Health, Price
Waterhouse Coopers (PwC) is
reviewing the Fifth Community
Pharmacy Agreement medication
management programs, including
HMR and MedsCheck services.
The Pharmacy Guild of Australia
said the review aimed to better
inform how the programs
contributed to improved consumer
health outcomes and future
investment in these services.
PwC will run up to seven
provider focus groups, including
pharmacists, of which one had
been conducted via teleconference
and up to another six were
scheduled over March to April.
These groups sought to
understand provider experiences
in delivering or referring the
services, including challenges and
barriers and perceived outcomes, a
spokeswoman for the Department
of Health said.
Up to 10 consumer focus groups
were planned as well, two of which
had been conducted already, in
QLD and SA, with a further eight
scheduled in various locations.
As focus groups had only recently
commenced, it was premature to
provide feedback at this point, the
Department said.
The review is due for completion
in December.
Interest can be registered HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Mar 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Mar 14
